Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122532392 | 12253239 | 2 | F | 201509 | 20160909 | 20160411 | 20160912 | EXP | US-GLAXOSMITHKLINE-US2016044293 | GLAXOSMITHKLINE | 74.95 | YR | F | Y | 0.00000 | 20160912 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122532392 | 12253239 | 1 | PS | ACYCLOVIR. | ACYCLOVIR | 1 | Oral | UNK | U | UNKNOWN | 18603 | ||||||||
| 122532392 | 12253239 | 2 | SS | OMEGA-3-ACID ETHYL ESTERS. | OMEGA-3-ACID ETHYL ESTERS | 1 | Oral | 2 G, BID | Y | 27656301 | 0 | 2 | G | CAPSULE | BID | ||||
| 122532392 | 12253239 | 3 | SS | LOVAZA | OMEGA-3-ACID ETHYL ESTERS | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 122532392 | 12253239 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 5 | C | DIOVAN | VALSARTAN | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 6 | C | NOVOLOG | INSULIN ASPART | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 7 | C | LANTUS | INSULIN GLARGINE | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 8 | C | ASPIRIN. | ASPIRIN | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 9 | C | AMLODIPINE BESILATE | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 10 | C | PRAVASTATIN SODIUM. | PRAVASTATIN SODIUM | 1 | U | 0 | |||||||||||
| 122532392 | 12253239 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122532392 | 12253239 | 2 | Myocardial infarction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122532392 | 12253239 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122532392 | 12253239 | Blood pressure increased | |
| 122532392 | 12253239 | Drug hypersensitivity | |
| 122532392 | 12253239 | Erythema | |
| 122532392 | 12253239 | Heart rate irregular | |
| 122532392 | 12253239 | Hypertension | |
| 122532392 | 12253239 | Malaise | |
| 122532392 | 12253239 | Pain | |
| 122532392 | 12253239 | Product substitution issue | |
| 122532392 | 12253239 | Therapeutic response changed |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122532392 | 12253239 | 1 | 201509 | 201509 | 0 | |
| 122532392 | 12253239 | 2 | 20160201 | 20160330 | 0 | |
| 122532392 | 12253239 | 3 | 201009 | 201602 | 0 |